glp 1 and colonoscopy prep Impact of GLP-1 Receptor Agonists in Gastrointestinal Endoscopy: An Updated Review GLP-1 Constipation: Miralax vs Metamucil

Description

This data reveals patterns

The Ozempic lawsuit saw case totals rise from 2,809 in October to 2,914 in November

Numerous patients have reported gastrointestinal issues after taking the drug, including gastroparesis or stomach paralysis

All of these findings are consistent with the concept that GLP-1 receptor agonists inhibit eating and reduce body weight primarily by acting directly in the brain, and that various brain areas are involved in mediating the eating-inhibitory effects of GLP-1 receptor agonists

Mioduchoski, FNP-BC Medical Weight Loss, Wellness & Peptide Therapy Last Updated: July 2026 Information is reviewed regularly to reflect current insurance policies, Medicare guidance, physician-reviewed treatment recommendations, and clinical best practices